VIRACEPT in combination with other antiretroviral agents is indicated for the treatment of HIV infection. Description of Studies. In the clinical studies described below, efficacy was evaluated by the percent of patients with plasma HIV RNA < 400…
TRUVADA ?, a combination of EMTRIVA and VIREAD ?, is indicated in combination with other antiretroviral agents (such as non-nucleoside reverse transcriptase inhibitors or protease inhibitors) for the treatment of HIV-1 infection in adults. The…
Ranitidine is indicated in: Short-term treatment of active duodenal ulcer. Most patients heal within 4 weeks. Studies available to date have not assessed the safety of ranitidine in uncomplicated duodenal ulcer for periods of more than 8 weeks…
VIREAD is a nucleotide analog HIV-1 reverse transcriptase and HBV polymerase inhibitor. Viread is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults. (1) Viread is indicated for the treatment of…
EPIVIR is a nucleoside analogue indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV-1) infection. Limitation of use: The dosage of this product is for HIV-1 and not for HBV. EPIVIR is a…
As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.
Terms of Use | Copyright © 2023. All Rights Reserved.